This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada & Co.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Denis Riendeau
Introduction
Denis Riendeau is a notable inventor based in Pierrefonds, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of assays that are crucial for understanding cellular processes.
Latest Patents
One of his key inventions is a patent titled "Whole cell assay for cathepsin K activity." This invention relates to a whole cell assay designed to determine cathepsin K activity in mammalian cell systems. It is particularly useful for identifying and evaluating inhibitors of cathepsin K, which plays a vital role in various biological processes.
Career Highlights
Denis Riendeau is associated with Merck Frosst Canada & Co., a leading pharmaceutical company. His work there has allowed him to focus on innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Denis has collaborated with several professionals, including David Claveau and Joseph A Mancini. These collaborations have enhanced the research and development of his inventions.
Conclusion
Denis Riendeau's contributions to the field of biochemistry through his innovative patent demonstrate his commitment to advancing scientific knowledge and improving health outcomes. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile